These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37886115)

  • 1. BDNF gene Val66Met polymorphisms as a predictor for clinical presentation in schizophrenia - recent findings.
    Farcas A; Hindmarch C; Iftene F
    Front Psychiatry; 2023; 14():1234220. PubMed ID: 37886115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia.
    Chen SL; Lee SY; Chang YH; Chen SH; Chu CH; Wang TY; Chen PS; Lee IH; Yang YK; Hong JS; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():99-104. PubMed ID: 24468644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
    Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the brain-derived neurotrophic factor Val66Met polymorphism with negative symptoms severity, but not cognitive function, in first-episode schizophrenia spectrum disorders.
    Mezquida G; Penadés R; Cabrera B; Savulich G; Lobo A; González-Pinto A; Penzol MJ; Corripio I; Fernandez-Egea E; Gassó P; Cuesta MJ; Bernardo M;
    Eur Psychiatry; 2016 Oct; 38():61-69. PubMed ID: 27668551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.
    Liu J; Wang P; Sun L; Guan X; Xiu M; Zhang X
    Transl Psychiatry; 2021 Sep; 11(1):458. PubMed ID: 34482368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BDNF Val66Met polymorphism and clinical response to antipsychotic treatment in schizophrenia and schizoaffective disorder patients: a meta-analysis.
    Huang E; Hettige NC; Zai G; Tomasi J; Huang J; Zai CC; Pivac N; Nikolac Perkovic M; Tiwari AK; Kennedy JL
    Pharmacogenomics J; 2019 Jun; 19(3):269-276. PubMed ID: 30181602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Risk of Schizophrenia: A Meta-analysis of Case-Control Studies.
    Kheirollahi M; Kazemi E; Ashouri S
    Cell Mol Neurobiol; 2016 Jan; 36(1):1-10. PubMed ID: 26134309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and BDNF Val66Met polymorphism in male schizophrenia: a case-control study.
    Zhang XY; Chen DC; Tan YL; Luo X; Zuo L; Lv MH; Shah NN; Zunta-Soares GB; Soares JC
    J Psychiatr Res; 2015 Jan; 60():49-55. PubMed ID: 25455509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the brain-derived neurotrophic factor Val66Met polymorphism and therapeutic response to olanzapine in schizophrenia patients.
    Nikolac Perkovic M; Nedic Erjavec G; Zivkovic M; Sagud M; Uzun S; Mihaljevic-Peles A; Kozumplik O; Muck-Seler D; Pivac N
    Psychopharmacology (Berl); 2014 Sep; 231(18):3757-64. PubMed ID: 24595507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum BDNF and val66met polymorphism of the brain-derived neurotrophic factor in a sample of first psychotic episode patients.
    Rizos EN; Siafakas N; Stefanis N; Douzenis A; Kontaxakis V; Laskos E; Kastania A; Zoumbourlis V; Lykouras L
    Psychiatriki; 2009 Oct; 20(4):297-304. PubMed ID: 22218230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.
    Miura I; Zhang JP; Nitta M; Lencz T; Kane JM; Malhotra AK; Yabe H; Correll CU
    Schizophr Res; 2014 Feb; 152(2-3):365-72. PubMed ID: 24411528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum Levels.
    Ahmed AO; Kramer S; Hofman N; Flynn J; Hansen M; Martin V; Pillai A; Buckley PF
    Neuropsychobiology; 2021; 80(5):411-424. PubMed ID: 33706323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia].
    Sun MM; Liu LF; Yang LM; Wang Y; Cui KY; Wang LN; Li CL; Qiao DD; Wang RZ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):155-8. PubMed ID: 22487823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P
    J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders.
    Aas M; Haukvik UK; Djurovic S; Tesli M; Athanasiu L; Bjella T; Hansson L; Cattaneo A; Agartz I; Andreassen OA; Melle I
    J Psychiatr Res; 2014 Dec; 59():14-21. PubMed ID: 25246365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF Val66Met and clinical response to antipsychotic drugs: A systematic review and meta-analysis.
    Cargnin S; Massarotti A; Terrazzino S
    Eur Psychiatry; 2016 Mar; 33():45-53. PubMed ID: 26854986
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.